All In Biotech

Drug Trial Radar · NCT00767507

Maintenance of Platelet Inhibition With Cangrelor

BRIDGE: Maintenance of Platelet inihiBition With cangRelor After dIscontinuation of ThienopyriDines in Patients Undergoing surGEry

Last checked: Nov 20, 2026Latest source record: Apr 4, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 221 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

221

Actual

Start

Oct 2008

Primary completion

Jun 2011

Study completion Jul 2011

Sponsor

Lead sponsor
The Medicines CompanyIndustry
Sponsor type
Industry
First posted
Oct 7, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate that patients receiving cangrelor infusion before coronary artery bypass grafting have an acceptable safety profile and can undergo surgery without excessive bleeding peri-operatively.

Conditions

  • Acute Coronary Syndrome (ACS)

Interventions

  • cangrelorDrug

  • PlaceboOther

    Placebo IV infusion administered in the same fashion as the active study drug in order to maintain the blind in the study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Stage I: Percentage of Patient Samples That Maintained Platelet Inhibition Levels of Greater Than or Equal to 60% as Reported by the VerifyNow P2Y12 Point of Care Assay.Time frame: During study drug infusion up to 1-6 hours prior to surgery
  2. Stage II: The Percentage of Patients That Maintained Platelet Reaction Units (PRU) < 240, as Determined by the VerifyNow P2Y12 Point of Care Assay, Measured During Study Drug Infusion Pre-surgery.Time frame: During study drug infusion up to 1-6 hours prior to surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Scripps Clinic / Scripps Green Hospital

    La Jolla, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.